-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/prostate-cancer-surveillance_executive.pdf
December 01, 2011 - Incidence of metastatic disease
d. Quality of life
e. Costs
5. … No more than 20 percent of the
study sample could exhibit more advanced disease. … We also extracted
definitions of disease progression. … additional basic and clinical research is
needed to more accurately classify or predict those men
whose diseases … No trial provided results from comparisons of AS with RP
or RT in men with localized diseases.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/medical-test-reviews-applicability.ppt
June 01, 2012 - Spectrum effect
The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence
Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
-
effectivehealthcare.ahrq.gov/sites/default/files/medical-test-reviews-applicability.ppt
June 01, 2012 - Spectrum effect
The severity or type of disease may affect test accuracy. … Secular trends in population risk and disease prevalence
Prevalence is tied to disease definitions that … A simple change in definition can have a great impact on disease prevalence. … be diagnosed and have the course of their disease altered. … Has the treatment of the related disease improved or changed?
-
effectivehealthcare.ahrq.gov/sites/default/files/s123.pdf
October 01, 2007 - In addition, patients with more severe disease are assumed to
have lower survival odds regardless of … severity,
this leads to the following surgery choice model as a function
of disease severity:
S � c0 … If the survival risk of BCSI is thought to increase
with L (b1 � 0), the patients with higher disease … and disease severity in-
creases (eg, larger vs. smaller tumor size) as we move to the
right on the … In this case,
ESBC patients with the lowest disease severity and those with
the highest disease severity
-
effectivehealthcare.ahrq.gov/sites/default/files/13_pulmonary_potential_high_impact_june_2012.pdf
January 01, 2012 - Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 13: Pulmonary Disease … ES-2
Pulmonary Disease, Including Asthma, Interventions ........................................... … Priority Area 13: Pulmonary Disease, Including Asthma
Topic High Impact Potential
1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease No high-impact potential … The primary treatment goal is
to lessen symptoms and slow disease progression.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology,
Annals of Rheumatic Diseases … oral
DMARD:
Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists
and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE
BMJ
JAMA
LANCET
NEW ENGLAND JOURNAL OF MEDICINE
ANNALS OF THE RHEUMATIC DISEASES
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine_surveillance.pdf
March 01, 2013 - England Journal of Medicine), as well as these specialty journals: Rheumatology,
Annals of Rheumatic Diseases … oral
DMARD:
Mixed results for disease activity. … Legend: ACR: American College of Rheumatology; DAS: Disease Activity Score; DMARD: Disease-modifying … factor-alpha antagonists
and the risk of hospitalization for infection in patients with autoimmune diseases … MEDICINE
BMJ
JAMA
LANCET
NEW ENGLAND JOURNAL OF MEDICINE
ANNALS OF THE RHEUMATIC DISEASES
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/type-2-diabetes-medications-2007_executive.pdf
January 01, 2007 - Peripheral vascular disease. … morbidity, microvascular
disease, and peripheral vascular disease. … lactic acidosis would help
determine the safety of using this medication in
populations with comorbid diseases … , congestive heart failure,
liver disease, or psychiatric disease. … medications in effects on peripheral vascular disease.
2e.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-tests-outcomes_methods.pdf
July 01, 2012 - screening for reportable diseases
such as syphilis or HIV. … Numerous clinical management effects might follow testing for
coronary artery disease with CT. … An individual diagnosed with coronary disease might alter his or her lifestyle to
reduce disease progression … Although the prognoses for some diseases are minimally modifiable with current
treatments, most prognostic … Principles and
practice of mass screening for disease. WHO
Chronicle 1968;22:473.
8.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/case-management_executive.pdf
January 01, 2013 - Disease-Specific Health Outcomes
The effect of CM on disease-specific outcomes was
inconsistent. … Older adults
with one or more
chronic diseases
Mortality. … Older adults
with one or more
chronic diseases
Disease burden. … Older adults
with one or more
chronic diseases
Personal contact. … A taxonomy for disease
management: a scientific statement from the American Heart
Association Disease
-
effectivehealthcare.ahrq.gov/sites/default/files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - higher risk
disease. … Who dies of
http://www.effectivehealthcare.ahrq.gov/reports/final.cfm
20
disease? … progression
36 months No statistically significant
disease progression. … higher risk disease. … Do Not Know
subjects with T2c disease but not in T2b
subjects.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/tx-for-localized-prostate-cancer_surveillanceassesment_20120614.pdf
May 01, 2012 - higher risk
disease. … Who dies of
http://www.effectivehealthcare.ahrq.gov/reports/final.cfm
20
disease? … progression
36 months No statistically significant
disease progression. … higher risk disease. … Do Not Know
subjects with T2c disease but not in T2b
subjects.
-
effectivehealthcare.ahrq.gov/sites/default/files/pepticulcer_hi_impact.pdf
January 01, 2012 - (The therapy
has also recently been identified as being explored for other autoimmune diseases such … The rationale for this treatment
stems from the fact that inflammatory bowel diseases are rare in developing … The rationale for this treatment stems from the
fact that inflammatory bowel diseases are rare in developing … and other
inflammatory bowel diseases.
8
It does not appear that the manufacturer intends to … Bethesda (MD):
National Digestive Diseases Information
Clearinghouse; [accessed 2011 Jun 6]. [4 p
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/women-hiv_research-protocol.pdf
March 01, 2016 - , chronic kidney disease,
bone disease, hyperlipidemia, cancer, depression, and neurocognitive impairment … This may lead to delayed diagnosis and greater
disease burden for the individual. … Clinical infectious diseases : an official publication of the
Infectious Diseases Society of America … HIV infection and cardiovascular disease. European
heart journal. 2014;35(21):1373-1381.
12. … Psychological symptoms among persons 50 years of age and older living with
HIV disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/diabetes-foot-ulcer-amputation-incidence_research.pdf
January 01, 2011 - were determined to have diabetes if they had
two or more claims with International Classification of
Diseases … The
former set of ICD-9 codes represents the following
macrovascular diseases: peripheral arterial … disease,
myocardial infarction, heart failure, angina, and cere-
brovascular disease. … The latter set of ICD-9 codes
represents the following microvascular diseases: diabetic
renal disease … , diabetic ophthalmic disease, and diabetic
neurologic disease.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cad-women-treatment_executive.pdf
August 01, 2012 - – Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid disease? … – Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid disease? … • Coronary disease risk factors such as diabetes,
chronic kidney disease, or other comorbid
disease … Ischemic heart disease in women: facts and wishful
thinking.
-
effectivehealthcare.ahrq.gov/sites/default/files/searching.ppt
January 01, 2011 - Searches would include the disease, intervention, and terms for RCTs. … However, it is also sufficient to include the intervention, harms, and the disease of interest. … Arterial occlusive disease/
Peripheral vascular diseases/
Vascular diseases/
Atherosclerosis/
Cardiovascular … diseases/
Carotid artery diseases/
(((preserved adj left) or (stable adj cad) or (stable adj chd) or … adj lvef) or (normal adj ef)).mp
1 or 2 or 3 or 4 or 5 or 6 or 7 or 8 or 9 or 10
Terms for vascular diseases
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rheumatoid-arthritis-medicine-1_research.pdf
February 01, 2009 - rheumatoid arthritis, disease modifying anti-rheumatic drugs, epidemiology
Effective Health Care … Research Report Number 8
Introduction
The treatment of rheumatoid arthritis (RA) with disease modifying … anti-rheumatic drugs
(DMARDs) provides control of disease activity, slows joint erosions and improves … remission after 3 years.9,10 The
lack of information on disease duration or disease activity measurements … The changing
use of disease-modifying anti-rheumatic drugs in
individuals with rheumatoid arthritis
-
effectivehealthcare.ahrq.gov/sites/default/files/pulmonary_hi_impact.pdf
April 01, 2012 - Horizon Scanning System – Potential High
Impact Interventions Report
Priority Area 13: Pulmonary Disease … ES-2
Pulmonary Disease, Including Asthma, Interventions ........................................... … ES-2
AHRQ Healthcare
Horizon Scanning System
AHRQ Priority Area 13 – Pulmonary Disease … Priority Area 13: Pulmonary Disease (including Asthma)
1. … Roflumilast (Daliresp) for treatment of chronic obstructive pulmonary disease
Discussion
Pulmonary
-
effectivehealthcare.ahrq.gov/sites/default/files/branson-text.pdf
October 13, 2011 - providers
Slide 4
Characteristics of Patient Representatives
§ Have personal experience with the disease … § Are knowledgeable about treatment options and/or the science of the disease
§ Are able to be objective … groups may offer an opportunity to identify patients who
might be underrepresented (such as for rare diseases … Advocacy experience
§ Ability to represent other patients/survivors
§ Knowledge and skills related to disease … area
§ Alternate disease experience
§ Work experience
§ Education
§ Interview representatives.